1. Home
  2. VSTM vs CTEV Comparison

VSTM vs CTEV Comparison

Compare VSTM & CTEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • CTEV
  • Stock Information
  • Founded
  • VSTM 2010
  • CTEV 1980
  • Country
  • VSTM United States
  • CTEV United States
  • Employees
  • VSTM N/A
  • CTEV N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • CTEV
  • Sector
  • VSTM Health Care
  • CTEV
  • Exchange
  • VSTM Nasdaq
  • CTEV NYSE
  • Market Cap
  • VSTM 313.1M
  • CTEV 295.8M
  • IPO Year
  • VSTM 2012
  • CTEV N/A
  • Fundamental
  • Price
  • VSTM $5.82
  • CTEV $20.75
  • Analyst Decision
  • VSTM Strong Buy
  • CTEV Hold
  • Analyst Count
  • VSTM 8
  • CTEV 1
  • Target Price
  • VSTM $13.00
  • CTEV $19.00
  • AVG Volume (30 Days)
  • VSTM 882.3K
  • CTEV 82.7K
  • Earning Date
  • VSTM 03-20-2025
  • CTEV 05-07-2025
  • Dividend Yield
  • VSTM N/A
  • CTEV N/A
  • EPS Growth
  • VSTM N/A
  • CTEV N/A
  • EPS
  • VSTM N/A
  • CTEV N/A
  • Revenue
  • VSTM $10,000,000.00
  • CTEV $930,624,000.00
  • Revenue This Year
  • VSTM N/A
  • CTEV $2.18
  • Revenue Next Year
  • VSTM $867.23
  • CTEV $3.04
  • P/E Ratio
  • VSTM N/A
  • CTEV N/A
  • Revenue Growth
  • VSTM N/A
  • CTEV N/A
  • 52 Week Low
  • VSTM $2.10
  • CTEV $4.80
  • 52 Week High
  • VSTM $13.52
  • CTEV $35.96
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 41.02
  • CTEV N/A
  • Support Level
  • VSTM $5.68
  • CTEV N/A
  • Resistance Level
  • VSTM $6.89
  • CTEV N/A
  • Average True Range (ATR)
  • VSTM 0.49
  • CTEV 0.00
  • MACD
  • VSTM -0.16
  • CTEV 0.00
  • Stochastic Oscillator
  • VSTM 7.41
  • CTEV 0.00

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About CTEV CLARITEV CORPORATION

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Share on Social Networks: